ArticleFrontiers in neuroscience2026
Enhancing hematoma expansion prediction in hypertensive intracerebral hemorrhage based on habitat and perihematomal edema radiomics from non-contrast CT: a dual-center study.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Characterizing the microenvironmental habitats within the hematoma may yield crucial imaging biomarkers and improve the early prediction of hematoma expansion (HE) in patients with hypertensive intracerebral hemorrhage (HICH). Our objective was to construct and validate a combined model that integrates clinical data with whole-hematoma radiomics, habitat radiomics of the hematoma, and perihematomal edema (PHE) radiomics features extracted from non-contrast computed tomography (NCCT) images for preoperative HE prediction. Methods: This retrospective dual-center cohort of 353 HICH patients. Based on baseline NCCT images, radiomics features were extracted from the whole hematoma, three distinct habitats within the hematoma, and the PHE region. Five models were constructed: a clinical model, a whole-hematoma radiomics model, a habitat-based radiomics model, a PHE radiomics model, and a combined model. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results: The combined model integrated with smoking history, island sign, maximum distance of the PHE, and the whole-hematoma, habitat, and PHE radiomics models, achieved the best predictive performance. In the training, testing, and validation sets, the combined model predicted the area under the curve for HE as 0.951 (95% CI: 0.915-0.986), 0.937 (95% CI: 0.883-0.991), and 0.939 (95% CI: 0.888-0.989), respectively. Conclusion: The NCCT-based combined model integrating clinical data, whole-hematoma radiomics, habitat radiomics, and PHE radiomics improves HE prediction in patients with HICH, providing a noninvasive tool with potential for guiding treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.